On 25 November 2018, the Minister for Health, the Hon Greg Hunt MP, announced that the Australian Government would commit more than $100 million in additional funding to expand the Continuous Glucose Monitoring (CGM) Initiative.
Since 1 April 2017, the CGM Initiative has provided fully subsidised CGM products to children and young people under 21 years of age, with type 1 diabetes.
From 1 March 2019, the eligibility for access to this initiative was expanded to provide fully subsidised CGM products to the following groups of people:
- children and young people with conditions very similar to type 1 diabetes, such as cystic fibrosis related diabetes and neonatal diabetes, who require insulin;
- women with type 1 diabetes who are actively planning pregnancy, pregnant, or immediately post-pregnancy; and
- people with type 1 diabetes aged 21 years or older who have concessional status, and have a high clinical need to access CGM products.
As a result of the Government’s additional funding for this program, over 37,000 Australians will be eligible to receive fully subsidised CGM products.
The detailed eligibility criteria for the expanded CGM Initiative, and application forms, are available on the NDSS website.
Any decision to further expand the CGM Initiative would need to be considered against competing priorities in the Health Budget.
Media release1 March 2019 – Media release – launch of the CGM Initiative expansion
25 November 2018 – Media release – expansion of the CGM initiative
1 April 2017 – Media release – commencement of the CGM initiative